Hi there,

Democracy Now is committed to bringing you the stories and perspectives you won't hear anywhere else, from the peace activists demanding an end to war to Indigenous leaders fighting to stop fossil fuel extraction and save the planet. Our independent reporting is only possible because we’re funded by you—not by the weapons manufacturers when we cover war or gun violence, not by the oil, gas, coal, or nuclear companies when we cover the climate crisis. Can you donate $10 today to keep us going strong? Every dollar makes a difference. Right now a generous donor will DOUBLE your donation, making it twice as valuable to Democracy Now! Please do your part today, and thank you so much.
-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Donate

Pfizer-BioNTech Submits Vaccine Data on 5-to-11-Year-Olds to FDA; Mask Mandate Bans Halted in SC and AZ

HeadlineSep 29, 2021

Pfizer-BioNTech said Tuesday they submitted data to the Food and Drug Administration showing their vaccine to be safe and effective in children aged 5 to 11. An official request for the vaccine to be given to that age group will be made in the coming weeks. An FDA official previously said an authorization could come “in a matter of weeks, not months.” About 28 million U.S. children between 5 and 11 would become eligible for the shot, if approved.

A federal judge has temporarily blocked South Carolina’s statewide ban on school mask mandates. The ACLU of South Carolina argued the ban puts students with certain disabilities at significant risk.

Earlier this week, an Arizona judge ruled the state’s ban on public school mask mandates was unconstitutional.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top